Since its discovery in 2004, graphene is increasingly applied in various fields owing to its
unique properties. Graphene application in the biomedical domain is promising and …

In recent years, the significance of biosensors has increased rapidly due to the growing
demand for rapid detection of various biomarkers with high selectivity and sensitivity. Among …

β-Secretase1 (BACE1) catalyzes the rate-limiting step in the generation of amyloid-β
peptides, that is, the principal component involved in the pathology of Alzheimer's disease …

The Internet of Bio-Nano Things (IoBNT) is a transformative communication framework
characterized by heterogeneous networks comprising both biological entities and artificial …

The study of Alzheimer's disease (AD), the most common cause of dementia, faces
challenges in terms of understanding the cause, monitoring the pathogenesis, and …

Glial fibrillary acidic protein (GFAP) is a discriminative blood biomarker for many
neurological diseases, such as traumatic brain injury. Detection of GFAP in buffer solutions …

Abstract Two-dimensional (2d) materials have been used extensively in various fields due to
their unique physical and chemical properties. Among their diverse applications, field-effect …

Cancer is an incurable disease, and the treatment process is extremely painful. Early
detection may ease the treatment process and prevent cancer from spreading beyond the …

Owing to its outstanding physical properties, graphene has attracted attention as a
promising biosensor material. Field-effect-transistor (FET)-based biosensors are particularly …

Alzheimer's disease (AD) is one of the most common types of neurodegenerative disorders.
It is possible to identify AD early thanks to the measurement of specific biomarker levels …